Accumulation of p16Ink4a has been shown to promote tumor progression and age dependent co-morbidities, and clearance of p16-positive cells starting from mid-life suppressed tumor progression with aging, and other age-related tissue dysfunction [46]. Here, CDKN2A is linked to neoplasm.